Skip to content

Study on the median effective dose of ciprofol for general anesthesia induction in elderly patients with Parkinson's disease

Study on the median effective dose of ciprofol for general anesthesia induction in elderly patients with Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111439
Enrollment
Unknown
Registered
2025-10-31
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Elderly Parkinson's disease patients induced with ciprofol:None

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.ASA physical status I-II; 2.BMI 18.5-29.9 kg/m^2; 3.Elderly patients aged 60-79 years; 4.Parkinson's disease patients undergoing elective stereotactic deep brain electrode implantation; 5.Having signed the informed consent form; 6.No restriction on gender;

Exclusion criteria

Exclusion criteria: 1.History of allergy to ciprofol or its excipients; 2.Uncontrolled or poorly controlled cardiovascular, respiratory, hepatic, or renal diseases; 3.Predicted difficult airway (modified Mallampati score of grade ?); 4.History of alcoholism or drug abuse; 5.Bispectral index (BIS) < 90 before induction; 6.History of mental illness; 7.Hearing impairment or inability to follow instructions;

Design outcomes

Primary

MeasureTime frame
Successful sedation for general anesthesia induction;

Secondary

MeasureTime frame
Heart rate;Blood pressure;

Countries

China

Contacts

Public ContactNie Chaoran

Xuanwu Hospital Capital Medical University

837642716@qq.com+86 188 1076 7357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026